Combination Angiotensin Converting Enzyme and Direct Renin Inhibition in Heart Failure following Experimental Myocardial Infarction
KA Connelly, A Advani, S Advani, Y Zhang, K Thai, S Thomas, H Krum, DJ Kelly, RE Gilbert
Cardiovascular Therapeutics | WILEY | Published : 2013
Awarded by NHMRC
This study was supported by a grant from Novartis Pharma and Canadian Institutes of Health Research. Ms. Christine Botelho provided invaluable expertise in animal handling. Dr. Kim Connelly was supported by a HSF Canada Phase 1 clinician scientist award, a TACTICS scholarship (Canada) and a NHMRC Neil Hamilton Fairley scholarship ID 440712. Dr. Richard Gilbert holds a Canada Research Chair in Diabetes Complications and this study was funded, in part, by the Canada Research Chair Program.Drs Krum, Gilbert, Kelly, Advani and Connelly have received research support and/or consulting fees from Novartis, the makers of Aliskiren.